Rita Spathis
Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis
BackgroundInefficient transduction is a major limitation in achieving therapeutic levels of AAV-delivered microdystrophin capable of improving muscle function in patients with Duchenne muscular dystrophy. Additionally, some patients experience acute co…